109 related articles for article (PubMed ID: 33597402)
41. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
[TBL] [Abstract][Full Text] [Related]
42. The Antiviral Effect of Indonesian Medicinal Plant Extracts Against Dengue Virus In Vitro and In Silico.
Rosmalena R; Elya B; Dewi BE; Fithriyah F; Desti H; Angelina M; Hanafi M; Lotulung PD; Prasasty VD; Seto D
Pathogens; 2019 Jun; 8(2):. PubMed ID: 31234495
[TBL] [Abstract][Full Text] [Related]
43. Antiviral activity of ST081006 against the dengue virus.
Lee JK; Chui JLM; Lee RCH; Kong HY; Chin WX; Chu JJH
Antiviral Res; 2019 Nov; 171():104589. PubMed ID: 31421165
[TBL] [Abstract][Full Text] [Related]
44. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
45.
Balinsky CA; Schmeisser H; Wells AI; Ganesan S; Jin T; Singh K; Zoon KC
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974568
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic effects of the root extracts of Eurycoma longifolia Jack.
Nurhanan MY; Azimahtol Hawariah LP; Mohd Ilham A; Mohd Shukri MA
Phytother Res; 2005 Nov; 19(11):994-6. PubMed ID: 16317660
[TBL] [Abstract][Full Text] [Related]
48. Hirsutine, an Indole Alkaloid of
Hishiki T; Kato F; Tajima S; Toume K; Umezaki M; Takasaki T; Miura T
Front Microbiol; 2017; 8():1674. PubMed ID: 28912773
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of dengue antiviral candidates in vivo in mouse model.
Watanabe S; Vasudevan SG
Methods Mol Biol; 2014; 1138():391-400. PubMed ID: 24696350
[TBL] [Abstract][Full Text] [Related]
50. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.
Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N
PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762
[TBL] [Abstract][Full Text] [Related]
51. Anti-dengue virus serotype 2 activity of tannins from porcupine dates.
Pong LY; Yew PN; Lee WL; Lim YY; Sharifah SH
Chin Med; 2020; 15():49. PubMed ID: 32467721
[TBL] [Abstract][Full Text] [Related]
52. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a murine model of non-lethal, symptomatic dengue virus infection.
Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT
Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699
[TBL] [Abstract][Full Text] [Related]
54. Validation of the Pockit Dengue Virus Reagent Set for Rapid Detection of Dengue Virus in Human Serum on a Field-Deployable PCR System.
Tsai JJ; Liu LT; Lin PC; Tsai CY; Chou PH; Tsai YL; Chang HG; Lee PA
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29436418
[TBL] [Abstract][Full Text] [Related]
55. Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried Water Extract of Eurycoma longifolia for the Improvement of Quality of Life and Sexual Well-Being in Men.
Ismail SB; Wan Mohammad WM; George A; Nik Hussain NH; Musthapa Kamal ZM; Liske E
Evid Based Complement Alternat Med; 2012; 2012():429268. PubMed ID: 23243445
[TBL] [Abstract][Full Text] [Related]
56. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo.
Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029
[TBL] [Abstract][Full Text] [Related]
57. An RT-PCR panel for rapid serotyping of dengue virus serotypes 1 to 4 in human serum and mosquito on a field-deployable PCR system.
Tsai JJ; Liu WL; Lin PC; Huang BY; Tsai CY; Chou PH; Lee FC; Ping CF; Lee PA; Liu LT; Chen CH
PLoS One; 2019; 14(3):e0214328. PubMed ID: 30908535
[TBL] [Abstract][Full Text] [Related]
58. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
59. Complex interaction between dengue virus replication and expression of miRNA-133a.
Castillo JA; Castrillón JC; Diosa-Toro M; Betancur JG; St Laurent G; Smit JM; Urcuqui-Inchima S
BMC Infect Dis; 2016 Jan; 16():29. PubMed ID: 26818704
[TBL] [Abstract][Full Text] [Related]
60. A NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL.
Sucipto TH; Churrotin S; Setyawati H; Martak F; Mulyatno KC; Amarullah IH; Kotaki T; Kameoka M; Yotopranoto S; Soegijanto AS
Afr J Infect Dis; 2018; 12(1 Suppl):116-119. PubMed ID: 29619441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
